Cleared Traditional

K220085 - KRONUS IA-2 Autoantibody (IA-2Ab) ELISA Kit (FDA 510(k) Clearance)

Aug 2023
Decision
590d
Days
Class 2
Risk

K220085 is an FDA 510(k) clearance for the KRONUS IA-2 Autoantibody (IA-2Ab) ELISA Kit. This device is classified as a Tyrosine Phosphatase (ia-2) Autoantibody Assay (Class II - Special Controls, product code OIF).

Submitted by Kronus, Inc. (Star, US). The FDA issued a Cleared decision on August 24, 2023, 590 days after receiving the submission on January 11, 2022.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5660. The Device Is Used For The Semi-quantitative Determination Of Autoantibodies Against Tyrosine Phosphatase (ia-2) In Human Serum As An Aid In The Diagnosis Of Type 1 Diabetes Mellitus (autoimmune Mediated Diabetes)..

Submission Details

510(k) Number K220085 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 2022
Decision Date August 24, 2023
Days to Decision 590 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code OIF - Tyrosine Phosphatase (ia-2) Autoantibody Assay
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660
Definition The Device Is Used For The Semi-quantitative Determination Of Autoantibodies Against Tyrosine Phosphatase (ia-2) In Human Serum As An Aid In The Diagnosis Of Type 1 Diabetes Mellitus (autoimmune Mediated Diabetes).